O ROURKE & COMPANY Inc’s holdings in Eli Lilly and Company were worth $1,180,000 at the end of the most recent reporting period. WestEnd Advisors LLC raised its stake in shares of Eli Lilly and Company by 210.0% in the first quarter. Wealth Preservation Advisors LLC bought a new stake in shares of Eli Lilly and Company in the first quarter valued at $27,000. Check Out Our Latest Stock Report on Eli Lilly and CompanyEli Lilly and Company Company Profile(Free Report)Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. Recommended StoriesReceive News & Ratings for Eli Lilly and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eli Lilly and Company and related companies with MarketBeat.com's FREE daily email newsletter.